• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian journal of hospital pharmacy. >Has the Drug of Choice for Treating Critical Illness Delirium Been Established?: THE 'CON' SIDE
【24h】

Has the Drug of Choice for Treating Critical Illness Delirium Been Established?: THE 'CON' SIDE

机译：具有治疗临危疾病谵妄的首选药物吗？：“符合”侧面

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Of every 10 patients in the intensive care unit (ICU), 4 to 9 will experience delirium during their admission. The development and validation of delirium screening tools specific to the critically ill population, including those receiving mechanical ventilation, has enabled a greater understanding of the prevalence of delirium in the ICU and its considerable impact on patient outcomes. Patients with delirium have increased mortality, prolonged duration of mechanical ventilation and hospital and ICU length of stay, more long-term cognitive impairment, and increased likelihood of transfer to chronic care facilities. Although effective prevention of delirium is paramount, it also remains imperative to identify effective treatment strategies for patients who experience the syndrome.
机译：在重症监护病房（ICU）的每10名患者中，4至9名患者将在入学期间经历谵妄。 特定于批评人口的谵妄筛查工具的开发和验证，包括接受机械通气的人，使得更加了解ICU谵妄的患病率，并对患者结果产生了相当大的影响。 谵妄患者的死亡率增加，机械通气和医院的长期持续时间和ICU的逗留时间，更长期的认知障碍，以及转移到慢性护理设施的可能性增加。 虽然有效预防谵妄是至关重要的，但它仍然是识别经历综合症的患者的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号